Pipobroman
|
WikiDoc Resources for Pipobroman |
|
Articles |
|---|
|
Most recent articles on Pipobroman |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pipobroman at Clinical Trials.gov Clinical Trials on Pipobroman at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pipobroman
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pipobroman Discussion groups on Pipobroman Patient Handouts on Pipobroman Directions to Hospitals Treating Pipobroman Risk calculators and risk factors for Pipobroman
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pipobroman |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.
